Table 2. Toxicity.
| Maximum NCI-CTC toxicity grade per patient | ||||
|---|---|---|---|---|
| Grade | 1 | 2 | 3 | 4 |
| WBC | 5 (12%) | 0 | 1 (2%) | 1 (2%) |
| Neutrophils | 2 (5%) | 1 (2%) | 1 (2%) | 1a (2%) |
| Hemoglobin | 20 (47%) | 3 (7%) | 0 | 0 |
| Platelets | 19 (44%) | 3 (7%) | 2 (5%) | 0 |
| Ast/ALT | 17 (40%) | 9 (21%) | 5 (12%) | 0 |
| Bilirubinemia | 11 (26%) | 2 (52%) | 2 (5%) | 0 |
| Nausea/Vomiting | 14 (33%) | 5 (12%) | 1 (2%) | 0 |
| Diarrhea | 3 (7%) | 0 | 1 (2%) | 0 |
| Mucositis | 1 (2%) | 3 (7%) | 0 | 0 |
| Asthenia | 9 (21%) | 8 (19%) | 1 (2%) | 0 |
| Alopecia | 2 (5%) | 0 | 0 | 0 |
| Abdominal pain | 23 (54%) | 4 (9%) | 1 (2%) | 0 |
| Constipation | 5 (12%) | 1 (2%) | 0 | 0 |
| Neurology | 7 (16%) | 0 | 0 | 0 |
| Fever | 4 (9%) | 2 (5%) | 0 | 0 |
| Haematemesis | 0 | 0 | 0 | 1 (2%) |
NCI-CTC National Cancer Institute Common Toxicity Criteria
Febrile neutropenia